Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Archis Pharma LLC, priced at $2.8764 per EA under NDC 72819018603. Its NADAC has been published 177 times since Apr 5, 2023.
FDA first approved this application on Jun 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Archis Pharma LLCNDC
72819018603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212135FDA Approved
6/21/2022
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 177 times since Apr 5, 2023, and over the history we have for it it has risen 33.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8764 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $1.4080 (Aug 23, 2023) |
| 52-week high | $3.2150 |
| 52-week low | $2.8764 |
| Median price | $2.5599 |
| Average price | $2.4275 |
| Largest weekly change | +33.5% (Sep 20, 2023) |
| Weeks tracked | 177 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Archis Pharma LLC, is $2.8764 per EA (NDC 72819018603), effective Aug 19, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 33.2%. It has been tracked across 177 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Apr 5, 2023, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.4080 (Aug 23, 2023) to a high of $3.2150 (Mar 11, 2026), with a median of $2.5599 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMATINIB MESYLATE 400 MG TAB, is $2.0356 per EA — about 29% below IMATINIB MESYLATE 400 MG TAB.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 72819018603) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.